Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis.
about
Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production.Leishmania isoenzyme polymorphisms in Ecuador: relationships with geographic distribution and clinical presentation.Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis.Molecular genomic approaches to infectious diseases in resource-limited settingsMiltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.Cutaneous Manifestations of Human and Murine LeishmaniasisMucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon.Epidemiological and clinical changes in American tegumentary leishmaniasis in an area of Leishmania (Viannia) braziliensis transmission over a 20-year period.Molecular epidemiology of Leishmania (Viannia) guyanensis in French GuianaIFN-γ production to leishmania antigen supplements the leishmania skin test in identifying exposure to L. braziliensis infectionComparative evaluation of lesion development, tissue damage, and cytokine expression in golden hamsters (Mesocricetus auratus) infected by inocula with different Leishmania (Viannia) braziliensis concentrations.Immunoregulatory and Effector Activities in Human Cutaneous and Mucosal Leishmaniasis: Understanding Mechanisms of Pathology.Antihelminthic therapy and antimony in cutaneous leishmaniasis: a randomized, double-blind, placebo-controlled trial in patients co-infected with helminths and Leishmania braziliensis.Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune responseCutaneous leishmaniasis: recent developments in diagnosis and managementAge modifies the immunologic response and clinical presentation of American tegumentary leishmaniasis.Differential Gene Expression and Infection Profiles of Cutaneous and Mucosal Leishmania braziliensis Isolates from the Same Patient.The gp63 Gene Cluster Is Highly Polymorphic in Natural Leishmania (Viannia) braziliensis Populations, but Functional Sites Are Conserved.Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects.Association between an emerging disseminated form of leishmaniasis and Leishmania (Viannia) braziliensis strain polymorphisms.Changes in T-Cell and Monocyte Phenotypes In Vitro by Schistosoma mansoni Antigens in Cutaneous Leishmaniasis Patients.Insulin-like growth factor-I serum levels and their biological effects on Leishmania isolates from different clinical forms of American tegumentary leishmaniasis.American tegumentary leishmaniasis caused by Leishmania (Viannia) braziliensis: assessment of parasite genetic variability at intra- and inter-patient levelsRecent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasisAtypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil.Geographic clustering of leishmaniasis in northeastern Brazil.Functional dichotomy of dendritic cells following interaction with Leishmania braziliensis: infected cells produce high levels of TNF-alpha, whereas bystander dendritic cells are activated to promote T cell responses.Cutaneous leishmaniasis: disease susceptibility and pharmacogenetic implications.Genetic risk factors for human susceptibility to infections of relevance in dermatology.Host genetic factors in American cutaneous leishmaniasis: a critical appraisal of studies conducted in an endemic area of Brazil.Identification and Biological Characterization of Leishmania (Viannia) guyanensis Isolated from a Patient with Tegumentary Leishmaniasis in Goiás, a Nonendemic Area for This Species in Brazil.Mucosal leishmaniasis: A Retrospective Study of 327 Cases from an Endemic Area of Leishmania (Viannia) braziliensis.GENOTYPE CHARACTERIZATION OF Leishmania (Viannia) braziliensis ISOLATED FROM HUMAN AND CANINE BIOPSIES WITH AMERICAN CUTANEOUS LEISHMANIASIS.Disseminated Leishmaniasis by Leishmania viannia Subgenus: A Series of 18 Cases in Southeastern Brazil.Protective and pathologic immune responses in human tegumentary leishmaniasis.An assessment of the genetic diversity of Leishmania infantum isolates from infected dogs in BrazilRecruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis.Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern BrazilGenotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot studyGenetic diversity of Leishmania amazonensis strains isolated in northeastern Brazil as revealed by DNA sequencing, PCR-based analyses and molecular karyotyping.
P2860
Q33241077-26ABB273-14FD-402B-85D4-A15FB19944EFQ33257308-2635165E-1EE1-4C5C-9E95-BDCEB0EACC8CQ33275038-DD38726F-7914-443E-9D13-5EADECEE1F6FQ33512515-6D631F99-F357-45DB-8B5D-6AA7EC60C13DQ33784151-29BFDF6F-2F0D-4C9E-BE85-719BD7AA924BQ33839048-F4C1B041-E0C3-4EE2-9359-4DDF100EAAFBQ33847397-B46F1E2D-BECD-413F-8F8F-9CB02B374126Q34189150-72BDD556-6F01-4FF2-A44A-7E934D36514AQ34430911-1416E3A1-CFD0-43BF-AE6E-53AE3A3FD996Q34535297-3831CB1D-E06D-4875-AFF8-B5F1530A78C7Q34595909-ED520031-4601-42AD-9B4B-73F81B1AF4B5Q34624834-CA74B7EA-6DD3-463D-B982-6C508B449F4FQ34707782-6F6107D0-14D7-493E-A623-E275A935FB31Q35168283-92732048-F525-4A98-AA33-58EAE734BEFFQ35187729-F742448F-89C5-4CAF-A740-C01D344F221CQ35692504-8ABF1CF7-7C01-4E9B-AFEA-FC54E40B5725Q35772188-A4672386-5C47-41C8-90AD-1ACB8FD729BBQ36138192-4DE321DA-58AA-4A35-9DDA-5616F0DDFEAFQ36209634-871F2A27-E806-424C-ABEA-5AA2076696A6Q36414186-5141F8ED-1DC5-40DC-A1EC-9F745B2B9EA3Q36417976-EF47E2AD-737F-4BE0-B98C-E4F0C6DC9ACAQ36994550-B2C881D0-9359-4E0E-B094-481A236B0CD2Q37060271-49CAA42D-D99A-4809-BFB4-FEF5F8D1BE52Q37251607-92585C4D-7155-41E5-A4D3-0A2728F1C62BQ37271204-DC5CB460-71DE-480D-8A43-53FED873FD3FQ37306452-49D5BC90-96DD-4AEF-BC86-64DEBDEC0949Q37367783-6813EECF-12C4-4BA4-8210-A84FC4E9DF1FQ37416125-29DFBD69-E74F-4A23-B0FB-F4CB96B2BB30Q37944170-67F74FE9-4EC0-4B00-A3F8-EFF0F3F8A2AFQ38215168-581B5AA6-4221-4812-9618-7622A48C4B6FQ39358089-58870B0C-505C-4935-9DD6-8BF5293D4B77Q40128507-592C6DC9-B889-41DE-813E-2E7AECA03899Q40708388-389C43EA-3C9B-4B47-A796-4F1B48DFA173Q41785783-E7FABA8E-0C26-4DF4-B5EA-0FD4CDED6953Q41971721-9EAC3226-AFBD-48F2-BB0C-F9462F5D8F8DQ41981494-44E2B207-3477-4B45-B9AA-C71E82E2BD03Q41983589-5985515E-B409-4270-A748-BD26AF41B83EQ42342346-4E4B600C-9004-4353-81E0-9E97C94865A3Q42367379-F88504B9-E66F-47E1-9F16-9F45531EBBF2Q42548599-6106007A-24E7-479E-B979-0A087B2A9D38
P2860
Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Multiclonal Leishmania brazili ...... can tegumentary leishmaniasis.
@en
type
label
Multiclonal Leishmania brazili ...... can tegumentary leishmaniasis.
@en
prefLabel
Multiclonal Leishmania brazili ...... can tegumentary leishmaniasis.
@en
P2093
P2860
P1476
Multiclonal Leishmania brazili ...... can tegumentary leishmaniasis.
@en
P2093
A L F Schriefer
A Ribeiro de Jesus
A Schriefer
E M Carvalho
L H Guimarães
L P Carvalho
P R Machado
R P Almeida
P2860
P304
P356
10.1128/IAI.72.1.508-514.2004
P407
P577
2004-01-01T00:00:00Z